StreetInsider.com Pre-Open Movers:
ArthroCare Corporation (Nasdaq: ARTC) 18% LOWER; to Restate Financials for 2006-07; Current Data Can No Longer Be Relied Upon
Genentech (NYSE: DNA) 15.6% HIGHER; Roche (OTC: RHHBY) has proposed to acquire Genentech for US$89.00 per share in cash.
Investors see a higher bid, driving the stock up to $94.60 this AM.
The Timken Company (NYSE: TKR) 12% HIGHER; sees Q2 EPS $0.96, ex-items, versus the company's previous estimate of $0.73 to $0.83 per share.
cash investorsPre-Open Movers 7/21: Genentech (DNA) Higher on Bid for Roche; B...StreetInsider.com News Articles Mon, 07/21/2008 - 08:21
|
